Explore more publications!
Idaho Healthcare Hub
Got News to Share?

Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 18, 2025

It’s the Balm Co. Brings Ancient Wisdom to Modern Skincare with the Oil Cleansing Method Using Grass-Fed Tallow Balm
November 18, 2025

It’s the Balm Co. Brings Ancient Wisdom to Modern Skincare with the Oil Cleansing Method Using Grass-Fed Tallow Balm

Indeterminate EIN Presswire
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025
November 18, 2025

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025

Indeterminate GlobeNewswire
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
November 18, 2025

Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease

Indeterminate GlobeNewswire
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025
November 18, 2025

SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

Indeterminate GlobeNewswire
Neurona Therapeutics Appoints Dr. Eduardo Dunayevich as Chief Medical Officer
November 18, 2025

Neurona Therapeutics Appoints Dr. Eduardo Dunayevich as Chief Medical Officer

Indeterminate GlobeNewswire
Solana Company Reports Third Quarter 2025 Financial Results
November 18, 2025

Solana Company Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
November 18, 2025

Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine

Indeterminate GlobeNewswire
argenx Announces Results of Extraordinary General Meeting of Shareholders
November 18, 2025

argenx Announces Results of Extraordinary General Meeting of Shareholders

Indeterminate GlobeNewswire
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
November 18, 2025

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire
Capsa Healthcare to Showcase Integrated Central Fill Automation at ASHP Midyear 2025
November 18, 2025

Capsa Healthcare to Showcase Integrated Central Fill Automation at ASHP Midyear 2025

Indeterminate GlobeNewswire
Comprehensive Healthcare Takes Next Step Toward Expanding Access to Behavioral Healthcare in Central Washington
November 18, 2025

Comprehensive Healthcare Takes Next Step Toward Expanding Access to Behavioral Healthcare in Central Washington

Indeterminate GlobeNewswire
SPRI and Neuromuscular Dynamics Launch NIH-Funded Clinical Trial to Advance Non-Surgical Knee Osteoarthritis Treatment
November 18, 2025

SPRI and Neuromuscular Dynamics Launch NIH-Funded Clinical Trial to Advance Non-Surgical Knee Osteoarthritis Treatment

Indeterminate GlobeNewswire
Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma
November 18, 2025

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma

Indeterminate GlobeNewswire
NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD After Successful Pilot Program
November 18, 2025

NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD After Successful Pilot Program

Indeterminate GlobeNewswire
ALX Oncology to Present at Upcoming Investor Conferences
November 18, 2025

ALX Oncology to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Sarah Scott Named to Business Insurance’s “Women to Watch” List for 2025
November 18, 2025

Sarah Scott Named to Business Insurance’s “Women to Watch” List for 2025

Indeterminate GlobeNewswire
Americans are More Anxious than Last Year About the Upcoming Holidays; Health Care and the Economy Also Major Concerns for Many
November 18, 2025

Americans are More Anxious than Last Year About the Upcoming Holidays; Health Care and the Economy Also Major Concerns for Many

Indeterminate GlobeNewswire
AUA and Urology Care Foundation Launch Groundbreaking Bridge Award to Sustain Urology Research
November 18, 2025

AUA and Urology Care Foundation Launch Groundbreaking Bridge Award to Sustain Urology Research

Indeterminate GlobeNewswire
MATTER Celebrates Companies Building Stronger Communities Through Volunteerism
November 18, 2025

MATTER Celebrates Companies Building Stronger Communities Through Volunteerism

Indeterminate GlobeNewswire
Paragonix Technologies Partnership with Gravitas Surgical Aims to Improve Donor Lung Viability and Availability on the US West Coast
November 18, 2025

Paragonix Technologies Partnership with Gravitas Surgical Aims to Improve Donor Lung Viability and Availability on the US West Coast

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions